Research
The first forecast to move up: heritable enhancement
Decomposed: roughly 0.85 that heritable editing to live birth happens again at all by 2126, given it has happened once and the original actor is rebuilding
Researched Sep 11, 2026 · published Sep 14, 2026
What changed
Decomposed: roughly 0.85 that heritable editing to live birth happens again at all by 2126, given it has happened once and the original actor is rebuilding; roughly 0.6 that at least one instance across a century is an enhancement at a locus carrying no disease variant; roughly 0.8 that it is verified and documented as such, as the first case was. That product is about 0.41, which is where the midpoint sits.
Evidence that moved the estimate
- It has already happened. Three children were born with intentional heritable edits, confirmed by official investigation, within about six years of CRISPR becoming usable, carried out by one funded individual against universal condemnation (hf-evidence-0042).
- Deterrence was real but not permanent: the actor served three years, was fined three million yuan, and has since resumed research and sought a permissive jurisdiction (hf-evidence-0042).
- Ten of 106 surveyed countries have no relevant policy at all, and the forecast needs one (hf-evidence-0043).
- Two arguments that appear to oppose the forecast do not survive inspection. Polygenic selection’s ceiling of about 2.5 IQ points or 2.5 centimetres is too low to absorb demand for large enhancement, and the most-cited safety statistic against CCR5 editing was retracted in 2019 over a genotyping artifact (hf-evidence-0046).
- Commercial appetite for engineering non-disease traits in offspring is demonstrably real today, sold as polygenic selection.
Evidence that held it back
- No country explicitly permits heritable editing and 75 of 96 with any policy prohibit initiating a pregnancy with a modified embryo (hf-evidence-0043).
- The traits people most want cannot be edited: height involves 12,111 significant SNPs across 21 percent of the genome, explaining only about 40 percent of variance (hf-evidence-0044).
- Embryo editing still produces mosaicism in roughly 14 to 25 percent of embryos, structural damage in about 16 percent of cells, and widespread loss of heterozygosity (hf-evidence-0045).
- Legal incentive pushes every actor to frame work as therapy, which suppresses the clean enhancement case even where enhancement occurs.
What would move it next
A heritable edit at a locus where the embryo carried no disease-associated variant, at any stage from approval to birth; and any jurisdiction moving from silence to explicit permission.